Lysophosphatidic acid attenuates the cytotoxic and degree of peroxisome proliferator-activated receptor γ activation induced by 15-deoxyΔ12,14-prostaglandin J2 in neuroblastoma cells

Biochemical Journal

Volumn 382, Issue 1, 2004, Pages 83-91

  Rodway, Helen A ^a   Hunt, Alan N ^b   Kohler, Janice A ^b   Postle, Anthony D ^b   Lillycrop, Karen A ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Apoptosis; Autophagy; Lysophosphatidic acid (LPA); Neuroblastoma; Peroxisome proliferator activated receptor (PPAR); Sphingosine 1 phosphate

Indexed keywords

CELL GROWTH; LIGANDS; LYSOPHOSPHATIDIC ACIDS; NEUROBLASTOMA CELLS;

ENZYME INHIBITION; ENZYMES; GENES; LIPIDS;

CELLS;

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIRINIXIC ACID; ROTTLERIN; SPHINGOSINE 1 PHOSPHATE; WORTMANNIN;

APOPTOSIS; ARTICLE; ATTENUATION; AUTOPHAGY; CANCER GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; GENE CONSTRUCT; GROWTH INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REPORTER GENE;

CELL DEATH; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; LIGANDS; LIPID METABOLISM; LIPIDS; LYSOPHOSPHOLIPIDS; NEUROBLASTOMA; PPAR GAMMA; PROSTAGLANDIN D2;

EID: 4344639257     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20040107     Document Type: Article

References (42)

1. Issemann, I. and Green, S. (1990) Activation of a member ot the steroid hormone receptor super-family by peroxisome proliterators. Nature (London) 347, 645-650
2. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G. and Wahli, W. (1992) Control of the peroxisomal β oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887
3. Sher, T., Yi, H. F., McBrie, O. W., and Gonzalez, F. J. (1993) cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32, 5598-5604
4. Greene, M. E., Blumberg, B., McBride, O. W., Yi, H. F., Kronquist, K., Kwan, K., Hsieh, L., Greene, G. and Nimer, S. D. (1995) Isolation of the human PPARγ cDNA: expression in haemopoietic cells and chromosomal mapping. Gene Expression 4, 281-299
5. Krey, G., Braissant, O., L'Horset, F., Kaikhoven, E., Petroud, M., Patker, M. G. and Wahli, W. (1997) Fatty acids, eicosanoids and hypolipidaemic agents identified as ligands of PPAFs by co-activator dependent receptor ligand assay. Mol. Endrocrinol. 11, 779-791
6. Forman, B. M., Chen, J. and Evans, R. M. (1997) Hypolipidaemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for PPARα and δ. Proc. Natl. Acad. Sci. U.S.A. 94, 4312-4317
7. Kliewsr, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, B. G., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M. and Lehmann, J. M. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. U.S.A. 94, 4318-1323
8. 2 is a ligand for the adipocyte determination factor, PPARγ. Cell 83, 803-612
9. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819
10. Davies, S. S., Pontsler, A. V., Marathe, G. K., Harrison, K. A., Murphy, R. C., Hinshaw, J. C., Prestwich, G. D., Hilaire, A. S., Prescott, S. M., Zimmerman, G. A. and McIntyre, T. M. (2001) Oxidized alkyl phospholipids are specific, high affinity peroxisome prolifetator-activated receptor gamma ligands and agonists. J. Biol. Chem. 276, 16015-16023
11. McIntyre, T. M., Pontsler, A. V., Silva, A. R., St Hilaire, A., Xu, Y., Hinshaw, J. C., Zimmerman, G. A., Hama, K., Aoki, J., Arai, H. and Prestwich, G. D. (2003) Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl. Acad. Sci. U.S.A. 100, 131-136
12. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K. and Wahli, W. (1993) Fatty acids and retinoids control lipid metabolism through the activation of PPAR/retinoid-X-receptor heterodimers. Proc. Natl. Acad. Sci. U.S.A. 90, 2160-2164
13. Jow, L. and Mukherjee, R. (1995) The human PPAR subtype NUC1 represses the activation of hPPARα and the thyroid hormone receptors. J. Biol. Chem. 270, 3836-3840
14. Lim, H. and Dey, S. K. (1999) PPARδ functions as a prostacyclin receptor in blastocyst implantation. Trends Endocrinol. Metab. 11, 137-142
15. Chawla, A., Schwarz, E. J., Dimaculangan, D. D. and Lazar, M. A. (1994) PPARγ: adipose predominant expression and induction in early adipocyte differentiation. Endocrinology 135, 798-800
16. Tontonoz, P., Hu, E. and Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid activated transcription factor. Cell 79, 1147-1156
17. Mukherjee, H., Jow, L., Croston, G. E. and Paterniti, Jr, J. H. (1997) Identification, characterization and tissue distribution of human PPAR isoforms PPARγ 2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272, 8071-8076
18. Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A. and Evans, R. M. (1999) PPARγ is required for placental, cardiac and adipose tissue development. Mol. Cell 4, 585-595
19. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. and Glass, C. K. (1998) The peroxisome proliferator activated receptor gamma is a negative regulator of macrophage activation. Nature (London) 391, 79-82
20. Harris, S. G. and Phipps, R. T. (2001) The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur. J. Immunol. 31, 1098-1105
21. Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E. M., Altiok, S., Oppenheim, H. et al. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for PPAR and trie retinoid-X receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 237-241
22. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C. and Spiegelman, B. M. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med. 4, 1046-1052
23. Elstner, E., Muller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D. and Koeffler, H. P. (1998) Ligands for PPARγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. U.S.A. 95, 8806-8811
24. Chang, T.-H. and Szabo, E. (2000) Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer. Cancer Res. 60, 1129-1138
25. Han, S. W., Greene, M. E., Pitts, J., Wada, R. K. and Sidell, N. (2001) Novel expression and function of peroxisome proliferator activated receptor gamma (PPARγ) in human neuroblastoma cells. Clin. Cancer Res. 7, 98-104
26. 12,14 prostaglandin J2, a specific ligand for peroxisome proliferator activated receptor γ induces neuronal apoptosis. Mol. Neurosci. 12, 839-843
27. Eichholtz, T., Jalink, K., Fahrenfort, L. and Moolenaar, W. H. (1993) The bioactive phospholipid lysophosphatidicacid is released from activated platelets. Biochem. J. 291, 677-680
28. Yatomi, Y., Igarashi, Y., Yang, L., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Ozaki, Y. and Kume, S. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. (Tokyo) 121, 969-973
29. Monard, D., Rentsch, M., Schuerch-Rathce, Y. and Lindsay, R. M. (1997) Morphological differentiation of neuroblastoma cells in medium supplemented with delipidated serum. Proc. Natl. Acad. Sci. U.S.A. 74, 3893-3897
30. Cham, B. E. and Knowles, B. R. (1976) A solvent system for delipidation of plasma or serum without protein precipitation. J. Lipid Res. 17, 176-181
31. Dignam, J. D., Lebobitz, R. M. and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
32. Burdge, G. C., Rodway, H. A., Kohler, J. A. and Lillycrop, K. A. (2001) Effect of fatty acid supplementation upon growth and differentiation of human IMR-32 neuroblastoma cells in vitro. J. Cell. Biochem. 80, 266-273
33. 2. Cell Growth Differ. 11, 49-61
34. Biederbeck, A., Kern, H. F. and Elsasser, H. P. (1995) Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur. J. Cell Biol. 66, 3-14
35. 2. J. Biol. Chem. 274, 17042-17048
36. 2 inhibits multiple steps in the NF-κB signalling pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 4844-4849
37. Kitanaka, C., Kato, K., Ijiri, R., Sakurada, K., Tomiyama, A., Noguchi, K., Nagashima, Y., Nakagawara, A., Momoi, T., Toyoda, Y. et al. (2002) Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. Int. Natl. Cancer Inst. 94, 358-368
38. Zackeri, Z., Bursch, W., Tenniswood, M. and Lockshin, R. A. (1995) Cell death: programmed, apoptosis, necrosis, or other? Cell Death Differ. 2, 87-96
39. Lynch, K. R. (2002) Lysophospholipid receptor nomeclature. Biochim. Biophys. Acta 1582, 70-71
40. Hu, E., Kim, J. B., Sarraf, P. and Spiegelman, B. M. (1996) Inhibition of adipogenesis through MAP kinase mediated phosphorylation of PPARγ. Science 274, 2100-2103
41. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A. and Chatterjee, V. K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen activated protein kinase site. J. Biol. Chem. 272, 5128-5132
42. Clay, C. E., Namen, A. M., Atsumi, G. I., Willingham, M. C., High, K. P., Kute, T. E., Trimboli, A. J., Fonteh, A. N., Dawson, P. A. and Chilton, F. H. (1999) Influence of J series prostaglandins on apoptosis and tumourigenesis of breast cancer cells. Carcinogenesis 20, 1905-1911